FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16459811000001102: CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57745301000001110 CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57745401000001119 CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Is a Mycophenolate mofetil 500mg tablets 50 tablet true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has AMP CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has specific active ingredient Mycophenolate mofetil true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
CellCept 500mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start